Expert Interviews: Scale-Up and Manufacturing
PHOENIX-OITB offers its customers GMP and non-GMP manufacturing and quality control for the development and manufacturing of nanoparticle formulations.
Within PHOENIX-OITB, MyBiotech GmbH focuses on formulation development and all CMC (chemistry, manufacturing and control)-related matters of nanopharmaceuticals. They are recognized for their advanced capabilities in novel drug delivery platforms, particularly in the field of nanopharmaceuticals, which they develop using a proprietary, proven, and scalable technology platform. Science-led services include process optimization, scale-up and tech transfer toward GMP manufacturing for pre-clinical and clinical testing – as well as quality control batch release, stability testing and clinical logistics.
Nazende Günday-Türeli, CEO of MyBiotech, is also Scientific Coordinator of PHOENIX-OITB and General Manager of PHOENIX SEP. She describes the manufacturing services of the PHOENIX-OITB and their benefits for customers, as well as MyBiotech’s role in demo cases.
